Literature DB >> 15331407

CD59a deficiency exacerbates ischemia-reperfusion injury in mice.

Daniel Turnberg1, Marina Botto, Margarita Lewis, Wuding Zhou, Steven H Sacks, B Paul Morgan, Mark J Walport, H Terence Cook.   

Abstract

The terminal complement components C5a and the membrane attack complex are involved in the pathogenesis of ischemia-reperfusion injury in many organs. CD59 is the major regulator of membrane attack complex formation. Mice deficient in the Cd59a gene (mCd59a-/-) were used to investigate the role of CD59 in renal ischemia-reperfusion injury. Unilateral ischemia-reperfusion injury was induced by clamping the left renal pedicle for 30 minutes under general anesthetic. Mice were studied at 72 hours and 2 weeks after ischemia-reperfusion injury. mCd59a-/- mice developed significantly greater tubular injury (P = 0.01), tubulointerstitial apoptosis (P = 0.02), and neutrophil influx (P = 0.04) than controls at 72 hours after ischemia-reperfusion. Two weeks after ischemia-reperfusion, mCd59a-/- mice exhibited more severe tubular damage predominantly in a corticomedullary distribution than controls (P = 0.02). Quantification of interstitial leukocytes revealed significantly greater numbers of infiltrating lymphocytes (but not macrophages) in mCd59a-/- mice than controls (P = 0.04) at 2 weeks. At both time points, significantly more C9 (as a marker of membrane attack complex) deposition occurred in a peritubular distribution in mCd59a-/- mice than controls. In conclusion, these results demonstrate that the lack of CD59a, by allowing unregulated membrane attack complex deposition, exacerbates both the tubular injury and the interstitial leukocyte infiltrate after ischemia-reperfusion injury in mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331407      PMCID: PMC1618586          DOI: 10.1016/S0002-9440(10)63345-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria.

Authors:  D S Holt; M Botto; A E Bygrave; S M Hanna; M J Walport; B P Morgan
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

2.  Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo.

Authors:  Aldo Dobrina; Mario Pausa; Fabio Fischetti; Roberta Bulla; Elena Vecile; Elisabetta Ferrero; Alberto Mantovani; Francesco Tedesco
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

3.  Complement (C5b-9) induces DNA synthesis in rat mesangial cells in vitro.

Authors:  W G Couser; J W Pippin; S J Shankland
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

4.  C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis.

Authors:  J Hughes; M Nangaku; C E Alpers; S J Shankland; W G Couser; R J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2000-05

5.  Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b.

Authors:  X Qin; T Miwa; H Aktas; M Gao; C Lee; Y M Qian; C C Morton; A Shahsafaei; W C Song; J A Halperin
Journal:  Mamm Genome       Date:  2001-08       Impact factor: 2.957

6.  Complement C5b-9 induces receptor tyrosine kinase transactivation in glomerular epithelial cells.

Authors:  A V Cybulsky; T Takano; J Papillon; A J McTavish
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

7.  Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.

Authors:  S Meri; B P Morgan; A Davies; R H Daniels; M G Olavesen; H Waldmann; P J Lachmann
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

8.  Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.

Authors:  Pierce Park; Mark Haas; Patrick N Cunningham; Jessy J Alexander; Lihua Bao; Joel M Guthridge; Damian M Kraus; V Michael Holers; Richard J Quigg
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

9.  Predominant role for C5b-9 in renal ischemia/reperfusion injury.

Authors:  W Zhou; C A Farrar; K Abe; J R Pratt; J E Marsh; Y Wang; G L Stahl; S H Sacks
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

10.  Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1alpha.

Authors:  S Saadi; R A Holzknecht; C P Patte; J L Platt
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

View more
  14 in total

1.  Crystal structure of C5b-6 suggests structural basis for priming assembly of the membrane attack complex.

Authors:  Alexander E Aleshin; Richard G DiScipio; Boguslaw Stec; Robert C Liddington
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

Review 2.  The role of complement in the early immune response to transplantation.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

3.  Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.

Authors:  Peng Zhu; Stefanie R Bailey; Biao Lei; Chrystal M Paulos; Carl Atkinson; Stephen Tomlinson
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

4.  Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.

Authors:  Carl Atkinson; Hongbin Song; Bo Lu; Fei Qiao; Tara A Burns; V Michael Holers; George C Tsokos; Stephen Tomlinson
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

5.  Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.

Authors:  Joshua M Thurman; Danica Ljubanović; Pamela A Royer; Damian M Kraus; Hector Molina; Nicholas P Barry; Gregory Proctor; Moshe Levi; V Michael Holers
Journal:  J Clin Invest       Date:  2006-01-26       Impact factor: 14.808

6.  The cellular origin and proliferative status of regenerating renal parenchyma after mercuric chloride damage and erythropoietin treatment.

Authors:  T-H Yen; M R Alison; H T Cook; R Jeffery; W R Otto; N A Wright; R Poulsom
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

7.  Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice.

Authors:  Denise Harhausen; Uldus Khojasteh; Philip F Stahel; B Paul Morgan; Wilfried Nietfeld; Ulrich Dirnagl; George Trendelenburg
Journal:  J Neuroinflammation       Date:  2010-03-04       Impact factor: 8.322

8.  Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury.

Authors:  Xiufen Zheng; Xusheng Zhang; Biao Feng; Hongtao Sun; Motohiko Suzuki; Thomas Ichim; Norihiko Kubo; Arthur Wong; Lisa R Min; Marianne E Budohn; Bertha Garcia; Anthony M Jevnikar; Wei-Ping Min
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

9.  C3a and C5a promote renal ischemia-reperfusion injury.

Authors:  Qi Peng; Ke Li; Lesley A Smyth; Guolan Xing; Naiyin Wang; Lucy Meader; Bao Lu; Steven H Sacks; Wuding Zhou
Journal:  J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 10.121

10.  Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice.

Authors:  Philip F Stahel; Michael A Flierl; B Paul Morgan; Ivonne Persigehl; Christiane Stoll; Claudia Conrad; Basel M Touban; Wade R Smith; Kathryn Beauchamp; Oliver I Schmidt; Wolfgang Ertel; Iris Leinhase
Journal:  J Neuroinflammation       Date:  2009-01-08       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.